Lupin Limited has informed the Exchange regarding a press release dated November 07, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Canagliflozin and MetforminHydrochloride Extended-Release Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated November 07, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Canagliflozin and MetforminHydrochloride Extended-Release Tablets.".